A 6-month randomized controlled trial to test the efficacy of a lifestyle intervention for weight gain management in schizophrenia (Q34590496)

3 August 2017

A 6-month randomized controlled trial to test the efficacy of a lifestyle intervention for weight gain management in schizophrenia (English)

1 reference

3 August 2017

0 references

1 reference

Rodrigo A Bressan

10

0 references

author name string

Cecília Attux

1

1 reference

3 August 2017

Larissa C Martini

2

1 reference

3 August 2017

Hélio Elkis

3

1 reference

3 August 2017

Sérgio Tamai

4

1 reference

3 August 2017

Andréa Freirias

5

1 reference

3 August 2017

Maria das Graças Miquelutti Camargo

6

1 reference

3 August 2017

Mário Dinis Mateus

7

1 reference

3 August 2017

Jair de Jesus Mari

8

1 reference

3 August 2017

André F Reis

9

1 reference

3 August 2017

18 February 2013

1 reference

3 August 2017

1 reference

3 August 2017

13

1 reference

3 August 2017

60

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-244x-13-60

3 August 2017

0 references

cites work

Effectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the U.S. Preventive Services Task Force

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599931

Standards of medical care in diabetes--2011.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599931

The Scandinavian Solutions for Wellness study - a two-arm observational study on the effectiveness of lifestyle intervention on subjective well-being and weight among persons with psychiatric disorders

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599931

Twenty-five year mortality of a community cohort with schizophrenia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599931

A 3-year randomized trial of lifestyle intervention for cardiovascular risk reduction in the primary care setting: the Swedish Björknäs study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599931

Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599931

Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599931

A Systematic Review of Mortality in Schizophrenia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599931

Interventions to reduce weight gain in schizophrenia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599931

The role of lifestyle interventions and weight management in schizophrenia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599931

International physical activity questionnaire: 12-country reliability and validity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599931

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599931

Validity study of the Brazilian version of the Calgary Depression Scale for Schizophrenia.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599931

Dietary intervention in primary care: validity of the DINE method for diet assessment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599931

The positive and negative syndrome scale (PANSS) for schizophrenia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599931

The impact of weight gain on quality of life among persons with schizophrenia.

7 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-60

Obesity as a risk factor for antipsychotic noncompliance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-60

The effectiveness of a non-pharmacological intervention for weight gain management in severe mental disorders: results from a national multicentric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-60

Distribution of HOMA-IR in Brazilian subjects with different body mass indexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-60

A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-60

A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-60

The Effects of an Educational Intervention on Antipsychotic‐Induced Weight Gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-60

Weight management program for treatment-emergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder: A 12-week randomized controlled clinical trial.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599931

The distribution of body mass index among individuals with and without schizophrenia.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3599931

The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia

27 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-13-60

The unhealthy lifestyle of people with schizophrenia

21 January 2018

1 reference

12 December 2020

[Application of the Portuguese version of the instrument for the assessment of quality of life of the World Health Organization (WHOQOL-100)]

1 reference

12 December 2020

Outcomes of obese, clozapine-treated inpatients with schizophrenia placed on a six-month diet and physical activity program

1 reference

12 December 2020

[Non-pharmacological interventions for weight gain in patients with schizophrenia taking antipsychotics]

1 reference

12 December 2020

[Impact of a lifestyle intervention program on metabolic, anthropometrical and dietary profile of Japanese-Brazilians with and without metabolic syndrome]

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-244X-13-60

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference

3 August 2017

1 reference